Agilent Technologies (A) Total Non-Current Liabilities (2009 - 2026)
Agilent Technologies (A) posted quarterly Total Non-Current Liabilities of $5.4 billion for Q2 2026, down 0.73% year-over-year from $5.5 billion in Q2 2025, and up 0.61% sequentially from $5.4 billion in Q1 2026.
Agilent Technologies (A) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Agilent Technologies has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $5.4 billion for Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities fell 0.73% year-over-year to $5.4 billion; the trailing twelve-month figure through Apr 2026 stood at $5.4 billion (down 0.73% YoY), and the FY2025 full-year result was $5.5 billion, up 2.85% from the prior year.
- Total Non-Current Liabilities was $5.4 billion for Q2 2026 at Agilent Technologies, up from $5.4 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $5.5 billion in Q4 2025 and troughed at $4.4 billion in Q4 2023.
- The 5-year median for Total Non-Current Liabilities is $5.3 billion (2022), against an average of $5.1 billion.
- Year-over-year, Total Non-Current Liabilities fell 13.93% in 2023 and increased 20.92% in 2024.
- Year by year, Total Non-Current Liabilities stood at $5.2 billion in 2022, then fell by 13.93% to $4.4 billion in 2023, then advanced by 20.92% to $5.4 billion in 2024, then climbed by 2.85% to $5.5 billion in 2025, then retreated by 1.38% to $5.4 billion in 2026.
- Per Business Quant, the three latest A Total Non-Current Liabilities figures stand at $5.4 billion (Q2 2026), $5.4 billion (Q1 2026), and $5.5 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 22.71 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 737.18 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | 8.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5.45 Bn |
| Jan 31, 2026 | 5.41 Bn |
| Oct 31, 2025 | 5.52 Bn |
| Jul 31, 2025 | 5.36 Bn |
| Apr 30, 2025 | 5.49 Bn |
| Jan 31, 2025 | 5.34 Bn |
| Oct 31, 2024 | 5.37 Bn |
| Jul 31, 2024 | 4.62 Bn |
| Apr 30, 2024 | 4.64 Bn |
| Jan 31, 2024 | 4.76 Bn |
| Oct 31, 2023 | 4.44 Bn |
| Jul 31, 2023 | 5.11 Bn |
| Apr 30, 2023 | 5.00 Bn |
| Jan 31, 2023 | 5.31 Bn |
| Oct 31, 2022 | 5.16 Bn |
| Jul 31, 2022 | 5.33 Bn |
| Apr 30, 2022 | 5.27 Bn |
| Jan 31, 2022 | 5.08 Bn |
| Oct 31, 2021 | 5.23 Bn |
| Jul 31, 2021 | 5.44 Bn |